HU9502663D0 - Bicyclic substituted oxazol- and thiazol-ethers - Google Patents

Bicyclic substituted oxazol- and thiazol-ethers

Info

Publication number
HU9502663D0
HU9502663D0 HU9502663A HU9502663A HU9502663D0 HU 9502663 D0 HU9502663 D0 HU 9502663D0 HU 9502663 A HU9502663 A HU 9502663A HU 9502663 A HU9502663 A HU 9502663A HU 9502663 D0 HU9502663 D0 HU 9502663D0
Authority
HU
Hungary
Prior art keywords
thiazol
ethers
bicyclic substituted
substituted oxazol
oxazol
Prior art date
Application number
HU9502663A
Other languages
English (en)
Other versions
HUT73432A (en
Inventor
William Joseph Houlihan
Jeffrey Nadelson
William Ronald James Simpson
Thomas D Aicher
Seung Hoon Cheon
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HU9502663D0 publication Critical patent/HU9502663D0/hu
Publication of HUT73432A publication Critical patent/HUT73432A/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU9502663A 1994-09-13 1995-09-12 Bicyclic substituted oxazol- and thiazol-ethers HUT73432A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30524994A 1994-09-13 1994-09-13

Publications (2)

Publication Number Publication Date
HU9502663D0 true HU9502663D0 (en) 1995-11-28
HUT73432A HUT73432A (en) 1996-07-29

Family

ID=23180015

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9502663A HUT73432A (en) 1994-09-13 1995-09-12 Bicyclic substituted oxazol- and thiazol-ethers

Country Status (26)

Country Link
EP (1) EP0702015B1 (hu)
JP (1) JPH08109183A (hu)
KR (1) KR960010649A (hu)
CN (1) CN1130186A (hu)
AT (1) ATE158585T1 (hu)
AU (1) AU3055295A (hu)
BR (1) BR9504004A (hu)
CA (1) CA2157950A1 (hu)
CO (1) CO4410332A1 (hu)
CZ (1) CZ229595A3 (hu)
DE (1) DE69500758T2 (hu)
DK (1) DK0702015T3 (hu)
ES (1) ES2108550T3 (hu)
FI (1) FI954257A (hu)
GR (1) GR3025405T3 (hu)
HU (1) HUT73432A (hu)
IL (1) IL115235A0 (hu)
MY (1) MY132008A (hu)
NO (1) NO953569L (hu)
NZ (1) NZ272976A (hu)
PE (1) PE50296A1 (hu)
PL (1) PL310372A1 (hu)
SI (1) SI0702015T1 (hu)
SK (1) SK111195A3 (hu)
TR (1) TR199501115A2 (hu)
ZA (1) ZA957699B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699866B2 (en) 2001-04-17 2004-03-02 Sepracor Inc. Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
DE10333935A1 (de) * 2003-07-25 2005-02-24 Aventis Pharma Deutschland Gmbh Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
FR2858321B1 (fr) * 2003-07-28 2006-01-20 Servier Lab Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1249992A (en) * 1983-11-10 1989-02-14 Marcel Muller Oxazolidines
ATE185564T1 (de) * 1992-08-31 1999-10-15 Sankyo Co Oxazolidin-derivate mit antidiabetika und anti- fettleibigkeit-eigenschaften, ihre herstellung und therapeutische verwendung
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
EP0645387A1 (en) * 1993-04-07 1995-03-29 Taiho Pharmaceutical Co., Ltd. Thiazolidine derivative and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
ZA957699B (en) 1997-03-13
AU3055295A (en) 1996-03-28
PE50296A1 (es) 1996-12-05
GR3025405T3 (en) 1998-02-27
FI954257A (fi) 1996-03-14
BR9504004A (pt) 1996-09-24
PL310372A1 (en) 1996-03-18
CN1130186A (zh) 1996-09-04
DK0702015T3 (da) 1998-01-12
DE69500758D1 (de) 1997-10-30
ES2108550T3 (es) 1997-12-16
DE69500758T2 (de) 1998-02-26
HUT73432A (en) 1996-07-29
CZ229595A3 (en) 1996-04-17
CO4410332A1 (es) 1997-01-09
SI0702015T1 (en) 1998-02-28
NZ272976A (en) 1996-09-25
NO953569D0 (no) 1995-09-11
JPH08109183A (ja) 1996-04-30
EP0702015B1 (en) 1997-09-24
FI954257A0 (fi) 1995-09-11
NO953569L (no) 1996-03-14
IL115235A0 (en) 1995-12-31
SK111195A3 (en) 1997-06-04
EP0702015A1 (en) 1996-03-20
TR199501115A2 (tr) 1996-06-21
MY132008A (en) 2007-09-28
ATE158585T1 (de) 1997-10-15
KR960010649A (ko) 1996-04-20
CA2157950A1 (en) 1996-03-14

Similar Documents

Publication Publication Date Title
NZ237565A (en) Substituted thiazolidinones, oxazolidinones or imidazolidinones and antiinflammatory pharmaceutical compositions thereof
AU8771591A (en) Retroviral protease inhibiting compounds
AU645672B2 (en) Agents for preserving technical materials against insects
GR3033350T3 (en) Use of Beta-aminopropionic acid derivatives as fungicides
DE69121259D1 (de) Beta-Lactam-Verbindungen und ihre Herstellung
AU2008995A (en) Improvements in or relating to organic compounds
BR9304780A (pt) Composto, processo para preparar o composto, composição farmacêutica e uso
HU9502663D0 (en) Bicyclic substituted oxazol- and thiazol-ethers
TW241264B (hu)
AU2704492A (en) Improvements in or relating to organic compounds
EP0381114A3 (en) Exo-3',4'-0-benzylidene-3"-demethylchartreusin and its salts
ATE166058T1 (de) Neue verbindung, leustroducsin h, ihre herstellung und therapeutische verwendung

Legal Events

Date Code Title Description
DGB9 Succession in title of applicant

Owner name: NOVARTIS AG., CH

DFD9 Temporary protection cancelled due to non-payment of fee